- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03943485
Utilization of Uterine Manipulator in Abdominal Hysterectomy
June 1, 2019 updated by: Huseyin Kiyak, Kanuni Sultan Suleyman Training and Research Hospital
Does Implementation of a Uterine Manipulator Prevent Vaginal Length and Sexual Funcation After Abdominal Hysterectomy
The investigators aimed to investigate whether the uterine manipulator which is usually utilized in laparoscopic hysterectomy would also be of benefit in preventing postoperative vaginal length and sexual function by facilitating the accurate localization fo the colpotomy site.
Patients scheduled for abdominal hysterectomy for benign causes will be randomized into two arms: Group 1 Uterine manipulator arm in which participants received a uterine manipulator during the procedure for aiding to locate the accurate colpotomy site and Group 2 consisting of control patients who will not receive uterine manipulator but undergo a standard abdominal hysterectomy.
Postoperative vaginal length, postoperative female sexual function index (FSFI) will be compared with the preoperative measurements in the two groups.
A 5 points Surgeon satisfaction scale will also be applied to the surgeons and residents performing the surgery to address their satisfaction in locating the colpotomy site.
Study Overview
Status
Completed
Conditions
Detailed Description
The uterine manipulator is a device that facilitates to locate the colpotomy site and visualization of surgical are during laparoscopic hysterectomy.
The investigators consider that adoption of the uterine manipulator will also facilitate to locate the colpotomy site in abdominal hysterectomy.
Therefore the investigators are planning to enroll patients undergoing an abdominal hysterectomy in this study.
Patients will be allocated into one of the study groups: Group 1 Uterine manipulator arm in which participants received a uterine manipulator during the procedure for aiding to locate the accurate colpotomy site and Group 2 consisting of control patients who will not receive uterine manipulator but undergo a standard abdominal hysterectomy.
All abdominal hysterectomies will be carried out by the same surgeon under general anesthesia.
One week before the surgery vaginal length will be measured and the female sexual function index (FSFI) will be obtained from all patients.
Following the surgery vaginal length will again be measured at 3 months and the female sexual function index (FSFI) will be obtained from participants by a research staff who is also a gynecologist.
Prevalence of postoperative dyspareunia will be asked to the patients at postoperative 3 months.
Just after the surgery, a 5 points surgeons' satisfaction scale will also be completed by the surgeons and residents performing the surgery to address their satisfaction in locating the colpotomy site either with the uterine manipulator as in group 1 or by manually guiding as in group 2.
Study Type
Interventional
Enrollment (Actual)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Please Enter The State Or Province
-
Istanbul, Please Enter The State Or Province, Turkey, 34005
- Kanuni Sultan Suleyman Training and Research Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 49 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Must be scheduled for total abdominal hysterectomy for benign causes Must be premenopausal Must be sexually active
Exclusion Criteria:
- Apical prolapsus Endometriosis Psychiatric disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Uterien Manipulator Arm
Patients in this group will receive a uterine manipulator during abdominal hysterectomy.
|
The uterine manipulator is primarily used in laparoscopic hysterectomy to accurately locate the colpotomy site.
We hypothesized that adoption of a uterine manipulator would help the surgeon to better identify the colpotomy site by moving the uterus cranially and thus providing better visualization of the colpotomy site.
|
NO_INTERVENTION: Control
Patients in this group will receive standard abdominal hysterectomy without adoption of a uterine manipulator.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vaginal length
Time Frame: Pre- to the postoperative 3 months
|
The change in vaginal length
|
Pre- to the postoperative 3 months
|
Female sexual function index (FSFI)
Time Frame: Pre- to the postoperative 3 months
|
The change in Female sexual function index score.
The Female Sexual Function Index (FSFI) is a brief multidimensional scale for assessing sexual function in women.
!9 questions concerning the sexual function are asked.
The minimum total score is 4 points.
A maximum total score of 36 indicates excellent sexual function.
Lower score indicate detoriorated sexual function.
|
Pre- to the postoperative 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Surgeons' satisfaction: Surgeons' satisfation score
Time Frame: Just after the surgery
|
Surgeons' satisfation score.
Surgeon satisfaction (SS) and resident satisfaction (RS) for determining the adequate colpotomy site will be evaluated at the end of the procedure surgeon's satisfaction score (SSS) which was scored by the surgical team performing the surgery on a five-point Likert scale as follows: 1 = Very difficult/very poor and 5 = Easy/Good (10).
The difference in SS and RS between the two groups will also be a secondary outcome of the present study.
|
Just after the surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 5, 2017
Primary Completion (ACTUAL)
May 15, 2019
Study Completion (ACTUAL)
May 20, 2019
Study Registration Dates
First Submitted
May 7, 2019
First Submitted That Met QC Criteria
May 8, 2019
First Posted (ACTUAL)
May 9, 2019
Study Record Updates
Last Update Posted (ACTUAL)
June 4, 2019
Last Update Submitted That Met QC Criteria
June 1, 2019
Last Verified
June 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Huseyin1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sexual Function Disturbances
-
Cairo UniversityUnknownSexual Function Disturbances | Urinary Function DisordersEgypt
-
Istanbul Medeniyet UniversityIstanbul UniversityNot yet recruitingQuality of Life | Hip Arthropathy | Sexual Function Disturbances
-
Maltepe UniversityCompletedGenitourinary Syndrome of Menopause | Sexual Function DisturbancesTurkey
-
School of Medicine - Vietnam National University...University of Medicine and Pharmacy at Ho Chi Minh City; Tu Du HospitalCompletedQuality of Life | Mayer Rokitansky Kuster Hauser Syndrome | Sexual Function DisturbancesVietnam
-
Medstar Health Research InstituteNot yet recruitingVaginal Atrophy | Postmenopausal Symptoms | Genitourinary Syndrome of Menopause | Sexual Function Disturbances | PRP
-
University of Roma La SapienzaCompleted
-
Chang Gung Memorial HospitalCompletedUrinary Bladder, Overactive | Sexual Behavior | Sexual Function Disturbances | Behavior Therapy | Sexual ActivityTaiwan
-
Assiut UniversityCompletedInflammatory Bowel Diseases | Sexual Function DisturbancesEgypt
-
Sorlandet Hospital HFOslo University HospitalRecruitingMyocardial Infarction | Sexual Function DisturbancesNorway
-
IRCCS San RaffaeleCompletedSystemic Sclerosis | Vulvovaginal Signs and Symptoms | Sexual Function DisturbancesItaly